---
title: "HUALI: In 2024, the net profit is 23.1013 million yuan, a year-on-year increase of 24.24%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237398175.md"
description: "HUALI announced that the operating revenue for 2024 is expected to be RMB 1.054 billion, a year-on-year increase of 33.00%. The net profit attributable to shareholders of the listed company is expected to be RMB 23.1013 million, a year-on-year increase of 24.24%. It plans to distribute a cash dividend of RMB 0.5 for every 10 shares to all shareholders based on the total share capital registered on the equity distribution registration date, without implementing a capital reserve transfer to increase share capital"
datetime: "2025-04-24T13:24:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237398175.md)
  - [en](https://longbridge.com/en/news/237398175.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237398175.md)
generator: "portal-rs"
---

# HUALI: In 2024, the net profit is 23.1013 million yuan, a year-on-year increase of 24.24%

HUALI announced that the operating revenue for 2024 is expected to be 1.054 billion yuan, a year-on-year increase of 33.00%. The net profit attributable to shareholders of the listed company is expected to be 23.1013 million yuan, a year-on-year increase of 24.24%. It is proposed to distribute a cash dividend of 0.5 yuan for every 10 shares to all shareholders based on the total share capital registered on the equity distribution registration date, without implementing a capital reserve transfer to increase share capital

### Related Stocks

- [603038.CN](https://longbridge.com/en/quote/603038.CN.md)

## Related News & Research

- [There's A Lot To Like About Zur Shamir Holdings' (TLV:ZUR) Upcoming ₪0.0916074 Dividend](https://longbridge.com/en/news/297594921.md)
- [Klaria Pharma plans listing of new warrants linked to rights issue at SEK 0.6 strike](https://longbridge.com/en/news/297582995.md)
- [EQU: Strong development, low vacancies, and robust demand underpin an optimistic outlook](https://longbridge.com/en/news/297301299.md)
- [Why You Might Be Interested In Alivus Life Sciences Limited (NSE:ALIVUS) For Its Upcoming Dividend](https://longbridge.com/en/news/297244607.md)
- [REG - China Pacific Insur. - Interim DIV. & Adj to the Conversion Price of CB](https://longbridge.com/en/news/297164098.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**